Satsuma Pharmaceuticals, Inc. Comprehensive Income
Satsuma Pharmaceuticals, Inc. reported Comprehensive Income of -$10.27 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-05-11
- Satsuma Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was -$10.27M.
- Satsuma Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was -$23.10M.
- Satsuma Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was -$15.10M.
- Satsuma Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-06-30 was -$16.25M.
- Satsuma Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$70.04M.
- Satsuma Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$51.24M.
- Satsuma Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$47.55M.
- Satsuma Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$28.16M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2023-03-31 | -$10.27M 10-Q · filed 2023-05-11 | -$33.37M derived: sum of 2 quarters · filed 2023-05-11 | -$48.46M derived: sum of 3 quarters · filed 2023-05-11 | -$64.72M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2022-12-31 | -$23.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$38.19M derived: sum of 2 quarters · filed 2023-03-28 | -$54.45M derived: sum of 3 quarters · filed 2023-03-28 | -$70.04M 10-K · filed 2023-03-28 | |
| 2022-09-30 | -$15.10M 10-Q · filed 2022-11-03 | -$31.35M derived: sum of 2 quarters · filed 2022-11-03 | -$46.95M 10-Q · filed 2022-11-03 | -$62.53M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2022-06-30 | -$16.25M 10-Q · filed 2022-08-09 | -$31.85M 10-Q · filed 2022-08-09 | -$47.43M derived: sum of 3 quarters · filed 2023-05-11 | -$60.77M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2022-03-31 | -$15.60M 10-Q · filed 2023-05-11 | -$31.18M derived: sum of 2 quarters · filed 2023-05-11 | -$44.52M derived: sum of 3 quarters · filed 2023-05-11 | -$56.36M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$15.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$28.92M derived: sum of 2 quarters · filed 2023-03-28 | -$40.76M derived: sum of 3 quarters · filed 2023-03-28 | -$51.24M 10-K · filed 2023-03-28 | |
| 2021-09-30 | -$13.34M 10-Q · filed 2022-11-03 | -$25.18M derived: sum of 2 quarters · filed 2022-11-03 | -$35.66M 10-Q · filed 2022-11-03 | -$48.20M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | -$11.84M 10-Q · filed 2022-08-09 | -$22.32M 10-Q · filed 2022-08-09 | -$34.86M derived: sum of 3 quarters · filed 2022-08-09 | -$47.05M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | -$10.48M 10-Q · filed 2022-05-10 | -$23.02M derived: sum of 2 quarters · filed 2022-05-10 | -$35.21M derived: sum of 3 quarters · filed 2022-05-10 | -$46.23M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$12.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$24.73M derived: sum of 2 quarters · filed 2022-03-15 | -$35.75M derived: sum of 3 quarters · filed 2022-03-15 | -$47.55M 10-K · filed 2022-03-15 | |
| 2020-09-30 | -$12.19M 10-Q · filed 2021-11-09 | -$23.21M derived: sum of 2 quarters · filed 2021-11-09 | -$35.02M 10-Q · filed 2021-11-09 | -$45.82M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | -$11.02M 10-Q · filed 2021-08-10 | -$22.82M 10-Q · filed 2021-08-10 | -$33.63M derived: sum of 3 quarters · filed 2021-08-10 | -$41.88M derived: sum of 4 quarters · filed 2021-08-10 | |
| 2020-03-31 | -$11.80M 10-Q · filed 2021-05-11 | -$22.61M derived: sum of 2 quarters · filed 2021-05-11 | -$30.86M derived: sum of 3 quarters · filed 2021-05-11 | -$37.15M derived: sum of 4 quarters · filed 2021-05-11 | |
| 2019-12-31 | -$10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$19.05M derived: sum of 2 quarters · filed 2021-03-25 | -$25.34M derived: sum of 3 quarters · filed 2021-03-25 | -$28.16M 10-K · filed 2021-03-25 | |
| 2019-09-30 | -$8.25M 10-Q · filed 2020-11-10 | -$14.54M derived: sum of 2 quarters · filed 2020-11-10 | -$17.35M 10-Q · filed 2020-11-10 | -$17.37M 10-Q · filed 2019-11-12 | -$19.70M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | -$6.29M 10-Q · filed 2020-08-11 | -$9.11M 10-Q · filed 2020-08-11 | -$11.45M derived: sum of 3 quarters · filed 2020-08-11 | -$13.04M derived: sum of 4 quarters · filed 2020-08-11 | |
| 2019-03-31 | -$2.81M 10-Q · filed 2020-05-12 | -$5.16M derived: sum of 2 quarters · filed 2020-05-12 | -$6.75M derived: sum of 3 quarters · filed 2020-05-12 | ||
| 2018-12-31 | -$2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$3.93M derived: sum of 2 quarters · filed 2020-03-10 | -$7.35M 10-K · filed 2020-03-10 | ||
| 2018-09-30 | -$1.59M 10-Q · filed 2019-11-12 | -$5.00M 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | -$5.17M 10-K · filed 2020-03-10 |